Seattle Children's Research Institute
Seattle, Washington, 98122, United States
NCT Number: NCT03137147
This study tests the feasibility, acceptability, and preliminary efficacy of a seven-session cognitive-behavioral therapy intervention to treat sleep and pain problems in youth ages 11-17 with co-morbid headache and insomnia.
Looking for future studies?
Notify Me11 year–17 year
All sexes
Interventional
Not applicable
Seattle, Washington, 98122, United States
Cognitive-behavioral interventions have been developed to treat childhood insomnia and childhood headache. In this study, we have combined strategies from these interventions into a single, seven-session protocol to treat sleep and pain problems in youth with co-morbid headache and insomnia. In this single-arm pilot study, we will test the feasibility, acceptability, and preliminary efficacy of this intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
See arm description.
Other names: Hybrid cognitive behavioral therapy for insomnia and headache
Time frame: 6-12 weeks
Number of completed intervention visits
Time frame: 6-12 weeks
Recruitment/Enrollment Rate
Time frame: 3 months
9-item self-report measure of treatment acceptability and satisfaction, scores range from 9-45, higher scores indicate greater treatment acceptability
Time frame: 3 months
7-item self-report measure of insomnia severity and impact, scores range from 0-28 with higher scores indicating greater insomnia symptoms.
Time frame: Past 4 weeks
28-item measure of subjective sleep quality, scores range from 28-168, higher scores indicate poorer sleep quality
Time frame: Past 2 weeks
Assesses pain frequency, intensity, onset, and duration.
Time frame: Past month
Assesses pain-related disability
Seattle Children's Hospital
Other
Intervention for Sleep and Pain in Youth: A Feasibility Study of Cognitive-Behavioral Intervention
Acronym: I-SPY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04936321
Brain Diseases, Central Nervous System Diseases
Seattle, Washington, United States
View Trial DetailsNCT07340788
Amino Acids, Peptides, and Proteins, Amylin
Glostrup Municipality, Denmark
View Trial DetailsNCT03632928
Brain Diseases, Central Nervous System Diseases
Glostrup Municipality, Denmark
View Trial DetailsNCT05153876
Brain Diseases, Central Nervous System Diseases
Ghent, Belgium
View Trial Details